Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07479004Not ApplicableCompleted

Effect of Cream Paste Containg Pleuran on Selected Skin Dermatoses (Neonatal Pustulosis, Diaper Dermatitis, Perioral Dermatitis).

Role: lead

NCT07460934Not ApplicableCompleted

Effect of Pleuran on the Clinical Course of Patients With Chronic Rhinosinusitis

Role: lead

NCT06974747Not ApplicableCompleted

Immunomodulatory Effect of Pleuran in Children With Recurrent Respiratory Tract Infections

Role: lead

NCT03988257Phase 4Completed

The Effectiveness of Pleuran in Treatment of Acute Gastroenteritis in Children

Role: collaborator

All 4 trials loaded